Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G

American Journal of Reproductive Immunology

Volumn 57, Issue 4, 2007, Pages 262-269

  Roussev, Roumen G ^a,c   Ng, Siu Chui ^a   Coulam, Carolyn B ^b  

^a Millenova Immunology Laboratories   (United States)

^b Pregnancy Success Center of the Rinehart Center for Reproductive Medicine   (United States)

^c NONE   (United States)

Author keywords

Intralipid; Intravenou simmuno globulin; Natural killer cell cytotoxicity; NKa; Soluble human leukocyte antigen G

Indexed keywords

FLUORESCENT DYE; HLA G ANTIGEN; IMMUNOGLOBULIN; INTRALIPID;

ARTICLE; BLOOD SAMPLING; CELL ACTIVITY; CELL FUNCTION; CELL LABELING; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INHIBITION KINETICS; NATURAL KILLER CELL; PREGNANCY DISORDER; PRIORITY JOURNAL; RECURRENT ABORTION;

ABORTION, HABITUAL; CELLS, CULTURED; FAT EMULSIONS, INTRAVENOUS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KILLER CELLS, NATURAL; PREGNANCY;

EID: 33947178928     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00473.x     Document Type: Article

References (65)

1. Croy BA, Gambel P, Rossant J, Wegmann TG: Characterization of murine decidual natural killer (NK) cells and their relevance to the success of pregnancy. Cell Immunol 1985; 93: 315-326.
2. Starkey PM, Sargent LL, Redman CWG: Cell populations in human early pregnancy deciduas: Characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 1988; 65: 129-134.
3. Clark DA, Vince G, Flanders KC, Kivte H, Starkey P: CD56+ lymphocytic cells in human first trimester deciduas as a source of a novel TGF- β 2-related immunosuppressive factors. Hum Reprod 1994; 9: 2270-2277.
4. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. J Immunol 1996; 156: 4027-4034.
5. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33: 40-46.
6. Kwak JYH, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE. Up-regulated expression of CD56+, CD56+/16+ and CD19+ cells in peripheral blood lymphocytes in woman with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34: 93-99.
7. Yokoyama M, Sano M, Sonoda K, Nozaki M, Nakamura GI, Nakano H. Cytotoxic cells directed against placental cells detected in human habitual abortions by in vitro terminal labeling assay. Am J Reprod Immunol 1994; 31: 197-204.
8. Kwak JYH, Kwak FMY, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively suppressed by immunoglobulin G infusions in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35: 363-369.
9. Coulam CB, Roussev RG: Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003; 20: 58-62.
10. Clark DA, Coulam CB, Stricker RB: Is IVIg efficacious in early pregnancy failure? J Assis Reprod Genet 2006; 23: 1-13.
11. Ruiz JE: Effect of Intravenous Immunoglobulin on Natural Killer Cell Activity in Women with Recurrent Spontaneous Abortion. Master Thesis, USA, Finch University of Health Science/The Chicago Medical School, 1995.
12. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED: HLA-G2,-G3, and G4 isoforms expressed as non-mature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001; 166: 5018-5026.
13. Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Weiss EH, Dichgans J, Lochmuller H, Hohlfeld R, Melms A, Weller M: The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 2003; 126: 176-185.
14. Granato D, Blum S, Rossle C, Le Boucher J, Malnos A, Dutot G. Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enterak Nutr 2000; 24: 113-118.
15. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W. Short-time infusion of fish-oil based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 2003; 171: 4837-4843.
16. Kane KL, Ashton FA, Schmitz JL, Folds JD: Determinations of natural killer cell function by flow cytometry. Clin Diag Lab Immunol 1996; 3: 295-300.
17. Sewell WAC, Jolles S: Immunomodulatory action of intravenous immunoglobulins. Immunol 2002; 107: 387-393.
18. Clark DA, Chaouat G: Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am J Reprod Immunol 2005; 53: 13-20.
19. Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Elis SA, McMichael AJ, Braud VM: Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999; 189: 1149.
20. Rajagopalan S, Long EO: A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999; 189: 1093-1100.
21. Le Bouteiller P, Blaschitz A: The functionality of HLA G is emerging. Immunol Rev 1999; 167: 233-244.
22. Krog J, Hoklland M, Ahlburg P, Parner E, Tonnesen E: Lipid solubility and concentration dependent attenuation of in vitro natural killer cell cytotoxicity by local anesthetics. Acta Anaesthesiol Scand 2002; 46: 875-881.
23. Inoue H, Miyaji M, Kosugi A, Nagafukku M, Okazaki T, Mimori T, Amakawa R, Fukuhara S, Domae N, Bloom ET, Umehara H: Lipid rafts as the signaling scaffold for NK cell activation: Tyrosine phosphorylation and association of LAT with phosphotidlyinositol 3-kinase and phospholipase C-gamma following CD2 stimulation. Eur J Immunol 2002; 32: 2188-2198.
24. Khan SA, Vanden-Heuvel JP: Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J Nutr Biochem 2003; 14: 554-567.
25. Kostenis E: A glance a G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkable diverse ligands. Pharmacol Ther 2004; 102: 243-257.
26. Clark DA: Intralipid as a treatment for recurrent unexplained abortion? Am J Reprod Immunol 1994; 32: 290-293.
27. Roussev RG, Kaider BD, Price DE, Coulam CB: Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol 1996; 35: 415-420.
28. Kaider AS, Kaider BD, Janowicz PB, Roussev RG: Immunologic evaluation in women with reproductive failure. Am J Reprod Immunol 1999; 42: 335-346.
29. Lédée-Bataille N, Dubanchet S, Coulomb-L'hermine A, Durand-Gasselin I, Frydman R, Chaouat G: A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004; 81: 59-65.
30. Coulam CB, RoussIv RG: Chemical pregnancies: immunologic and ultrasonographic studies. Am J Reprod Immunol 2002; 48: 323-328.
31. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996; 35: 352-359.
32. Clark DA, Daya S, Coulam CB, Gunby J: The Recurrent Miscarriage Immunotherapy Trialists Group: Implications of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35: 495-498.
33. Aoki K, Kajijura S, Matsumoto Y, Okada S, Yagami Y, Gleicher N: Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 1995; 135: 1340-1342.
34. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Preconceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with a normal karyotype. Am J Reprod Immunol 2003; 50: 351-354.
35. Clark DA, Croitoru K: TH1/TH2,3 imbalance due to cytokine-producing NK, γ δ T, and NK γ δ T cells in murine deciduas in success or failure of pregnancy. Am J Reprod Immunol 2001; 45: 108-115.
36. Mincheva-Nilsson L, Kling M, Hammarstrom S, Nagaeva O, Sundqvist KG, Hammarstrom ML, Baranov V: γ δ T cells of human early pregnancy decidua: Evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol 1997; 159: 3266-3277.
37. Nagaeva O, Bondestam K, Olofsson J, Damber MG, Mincheva-Nilsson L: An optimized technique for separation of human decidual leukocytes for cellular and molecular analyses. Am J Reprod Immunol 2002; 47: 203-212.
38. Nagaeva O, Jonsson L, Mincheva-Nilsson L: Dominant IL-10 and TGF-β mRNA expression in γ δ T cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 2002; 48: 9-17.
39. Szekeres-Bartho J, Barakonyi A, Miko E, Polgar B, Palkovics T: The role of γ/δ T cells in the feto-maternal relationship. Sem Immunol 2001; 13: 229-233.
40. Thomason EJ, Roussev RG, Stern JJ, Coulam CB: Prevalence of embryotoxic factor in sera from women with unexplained recurrent abortion. Am J Reprod Immunol 1995; 34: 338-341.
41. Hamai Y, Fujii T, Yamashita T, Miki A, Kozuma S, Geraghty DE, Taketani Y: Peripheral blood mononuclear cells from women with recurrent abortion exhibit an aberrant reaction to release cytokines upon the direct contact of human leukocyte antigen-G-expressing cells. Am J Reprod Immunol 1998; 40: 408-413.
42. Coulam CB, Krysa L, Stern JJ, Bustillo M: Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34: 333-337.
43. Kiprov DD, Nachtigall RD, Weaver RC, Jacaobson A, Main EK, Garvoy MR: The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 1996; 36: 228-234.
44. Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE: Successful treatment of immunological abortion with low-dose intravenous immunoglobulin. Fertil Steril 2000; 73: 536-540.
45. Stephenson MD, Dreher K, Houlihan E, Wu V: Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: A prospective, randomized, double-blind, placebo-controlled trial. Am J Reprod Immunol 1998; 39: 82-88.
46. The German RSA/IVIG Group. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994; 101: 1072-1077.
47. Chriatiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N: Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995; 10: 2690-2695.
48. Christiansen OB, Pedersen B, Rosgaard A, Husth M: A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: Evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002; 17: 809-816.
49. Perino A, Vassiliadis A, Vucetich A, Colacurci N, Menato G, Cignitti M, Semprini AE: Short-term therapy for recurrent abortion using intravenous immunoglobulins: Results of a double-blind placebo-controlled Italian study. Hum Reprod 1997; 12: 2388-2392.
50. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjelberg S, Lindton B: Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: A double-blind placebo-controlled study. Hum Reprod 1999; 14: 838-841.
51. Ratko TA, Burnett DA, Foulke GE, Matszewski KA, Sacher RA, and the University Hospital Consortium Expert Panel for Off-Label use of Polyvalent Intravenously Administered Immunoglobulin Preparations: Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995; 273: 1865-1870.
52. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarcelli B, Bencini E, Menicucci A, Baricordi OR: HLA-G expression in early embryos is fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32: 311-315.
53. Sher G, Keskintepe L, Nouriani M, Roussev R, Batzofin J: Expression of soluble HLA- G in supernatants of individually cultured 46-h embryos: A potentially valuable indicator of embryo competency and IVF outcome. Reprod Biomed Online 2004; 9: 74-79.
54. Noci I, Fuzzi B, Rizzo R, Melchiorri L, Criscuoli L, Dabizzi S, Biagiotti R, Pellegrini S, Menicucci A, Baricordi OR: Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005; 20: 138-146.
55. Roussev RG, Keskintepe L, Coulam CB, Sher G, Maasarani G: Soluble HLA-G (sHLA-G) in human embryo culture media: A useful marker for assessing embryo quality and implantation potential for IVF. Fertil Steril 2003; 80 (Suppl. 3): S12.
56. Roussev RG, Coulam CB: Detection of soluble HLA-G levels in embryo culture media is predictive for embryo quality and successful pregnancy in IVF. Am J Reprod Immunol 2004; 51: 471-472.
57. Pfiffer KA, Fimmers R, Engels G, van der Ven H, van der Ven K: The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001; 7: 373.
58. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C: Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000; 183: 682-688.
59. Kanai T, Fujii T, Kozuma S, Yasmasjita T, Miki A, Kikichi A, Taketani Y: Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 2001; 7: 195-200.
60. Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S: Lack of human leukocyte antigen-G expression in extravilous trophoblasts is associated with preeclampsia. Mol Hum Reprod 2000; 6: 88-95.
61. Gurgan T, Demirol A: Why and how should multiple pregnancies be prevented in assisted reproduction programmes? Reprod Biomed Online 2004; 9: 237-244.
62. Edwards RG and Brody SA: Principles and Practice of Assisted Human Reproduction. Philadelphia, USA, W.B. Saunders Co, 1995.
63. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC: Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189-194.
64. Daya S: Habitual abortion. In Textbook of Gynecology, 2nd edn. LJ Copeland, J Jarrel (eds). Philadelphia, WB Saunders, 2000, pp 227-271.
65. Johnson PM: A combined randomized double blind and open study of TMI in unexplained miscarriage. In Cellular and Molecular Biology of the Maternal-fetal Relationship. Chaouat G, Mowbray J (eds). Paris, INSERM/John Libby Eurotext, Colloque, Vol 212, 1991, pp 277-284.